Mode
Text Size
Log in / Sign up
N/A Completed N=2,032 Randomized Treatment

PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - XT Intermediate and High Risk

Symptomatic Severe Aortic Stenosis
Source: ClinicalTrials.gov NCT01314313 ↗
Enrolled (actual)
2,032
Serious AEs
70.1%
Results posted
Aug 2018
Primary outcomePrimary: All-cause Death or Disabling Stroke to Two Years — 192; 202 Participants

Summary

The purpose of this trial is to determine the safety and effectiveness of the Edwards SAPIEN XT transcatheter heart valve and delivery systems which are intended for use in patients with symptomatic, calcific, severe aortic stenosis.

Outcome Measures

OutcomeResultp-value
PRIMARY
All-cause Death or Disabling Stroke to Two Years
192; 202
SECONDARY
Adjusted Days Alive and Out of Hospital (DAOH) to Two Years
629.4; 597.8
SECONDARY
Total Aortic Regurgitation (AR) at 2 Years
1.2; 0.5
SECONDARY
6MWT Change From Baseline
14.5; NA
SECONDARY
NYHA Classification at 2 Years
1.5; 1.4
SECONDARY
Effective Orifice Area (EOA)
1.5; 1.4

Eligibility Criteria

Inclusion Criteria

  • Patient has senile degenerative aortic valve stenosis with echocardiographically derived criteria: mean gradient >40 mmHg or jet velocity greater than 4.0 m/s and an initial aortic valve area (AVA) of ≤0.8 cm2 or indexed EOA 3+).
  • Preexisting mechanical or bioprosthetic valve in any position (except NR3).
  • Any therapeutic invasive cardiac procedure resulting in a permanent implant that is performed within 30 days of the index procedure (unless part of planned strategy for treatment of concomitant coronary artery disease). Implantation of a permanent pacemaker or ICD (S3 Cohort only) is not excluded.
  • Heart team assessment of inoperability (including examining cardiac surgeon).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01314313). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search